News

Antibody deal with Janssen
Enlarge image

GenmabDenmark

Antibody deal with Janssen

17.07.2012 - When it comes to bispecific antibodies Genmab’s Duobody technology is becoming more and more popular, with Janssen Biotech now also reliant on it.

Danish Genmab A/S received an upfront payment of US$3,5m (DKK21m) from Janssen Biotech, Inc. – a Johnson & Johnson company from Horsham, Pennsylvania (USA). In return Genmab will create up to 10 panels for bispecific antibody production using its close to gold standard platform Duobody technology. No further details concerning the targeted diseases were revealed. All research will be fully funded by Janssen. Milestone and license payments of up to US$175m (DKK1.062m) for each product are additionally expected revenues – as are royalties on any product which will be commercialised.

After an unnamed pharmaceutical partner last December and Novartis last month, the Janssen deal is already the third and so far biggest agreement that Genmab could wrap up. The press announcement’s tone was therefore pretty confident: „Since the introduction of our Duobody platform in 2010, we have believed in its potential to become the preferred technology for next generation bispecific antibody therapeutics. Today's announcement is another indicator that the pharmaceutical industry recognises our leadership in the therapeutic antibody field“, said Jan van de Winkel, Chief Executive Officer of Genmab.

The Copenhagen company also stated that the deal likely will not have any material impact on its 2012 financial guidance.

http://www.european-biotechnology-news.com/news/news/2012-03/genmabs-golden-cash-cow.html

BusinessIreland

07.07.2015 Irish pharma play Allergan plc. is boosting its eye care business by acquiring US-American medtech company Oculeve. Included in the deal are Oculeve’s dry eye disease development programmes.

BusinessSwitzerland

03.07.2015 Biotech giant Biogen is investing CHF1bn in a new pharmaceutical production plant in the Swiss town of Luterbach. Noted as one of the world’s oldest biotech firms, Biogen will create up to 400 jobs at the new plant.

R&DNetherlandsSpainAustria

02.07.2015 Dutch biotech Amarna and Austrian Biomarker research centre CBmed have joined forces to develop several immunotherapies, including therapies against cancer and diabetes type 2. The joint venture will develop Amarna’s next generation viral vector platform.

M&ASwitzerland

30.06.2015 Pharma giant Novartis has bumped up its neuroscience portfolio with the recent purchase of Australian biotech Spinifex for a US$200m upfront payment plus US$500 in milestone payments. The acquisition is centred on Spinifex’ mid-stage pain drug EMA401.

Personalised MedicineGermany

25.06.2015 German immunotherapy expert BioNTech AG has partnered up with Europe’s largest engineering company Siemens to construct a manufacturing site for BioNTech’s personalised cancer vaccine.

Bioelectronic researchSweden

24.06.2015 Swedish scientists have created artificial neurons that are capable of mimicking the function of human nerve cells. The researchers hope that, once minituarised, they may one day be used to restore disturbed neural function.

FinancingLuxembourgItalySwitzerland

23.06.2015 Cosmo Pharmaceuticals is floating its majority-owned subsidiary Cassiopea at the Swiss Stock Exchange, with the aim to raise between CHF150m and CHF200m.

EventEUGermany

22.06.2015 For the 31st time, the ACHEMA has drawn the global chemical engineering and the process industry to Frankfurt. Although still overshadowed by petrol, the biobased economy is getting ready to step out into the limelight.

EventEU

17.06.2015 At the BIO convention in Philadelphia, the biotech industry celebrates new gene and cell therapies, and hails its unlikely superheroes.

ResearchUKSwitzerland

16.06.2015 Northern Ireland’s biopharma Almac Discovery is partnering up with Roche subsidiary Genentech in a two-year joint research programme to discover and develop cancer treatments.

Events

All Events

Current issue

All issues

Product of the week

Products